Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Akorn, Inc.: Gentamicin Sulfate Ophthalmic Solution Recalled for Crystalline Particles

Agency Publication Date: January 25, 2019
Share:
Sign in to monitor this recall

Summary

Akorn, Inc. is recalling approximately 149,159 bottles of Gentamicin Sulfate Ophthalmic Solution, USP 0.3% (5 mL), a prescription antibiotic eye drop used to treat bacterial eye infections. Crystalline particles were discovered in the solution during 24-month clarity testing, indicating the product may not be stable through its full shelf life. Consumers using these affected lots may be at risk of eye irritation or injury from the particulate matter.

Risk

The presence of crystalline particles in an ophthalmic solution can cause physical irritation, redness, or more serious abrasive damage to the delicate tissues of the eye when the drops are administered. No specific injuries have been reported in the provided data, but the presence of solids in a solution intended to be clear poses a safety risk to the user.

What You Should Do

  1. Check your medication cabinet for Gentamicin Sulfate Ophthalmic Solution, USP 0.3% in 5 mL dropper bottles with NDC 17478-283-10.
  2. Verify if your bottle matches the affected lot numbers and expiration dates: Lot 6C02A (Exp. 02/19), Lot 5K42A (Exp. 09/2018), or Lot 7D47A (Exp. 03/2020).
  3. If you have an affected bottle, contact your healthcare provider or pharmacist immediately to discuss alternative treatments and guidance for your specific medical condition.
  4. Return any remaining unused product to the pharmacy or place of purchase for a refund and further instruction.
  5. Contact the manufacturer, Akorn, Inc., for additional information regarding this recall.
  6. For further questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA).

Your Remedy Options

๐Ÿ’ฐFull Refund

Healthcare consultation and refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Gentamicin Sulfate Ophthalmic Solution, USP 0.3% (5 mL)
Model:
NDC 17478-283-10
Lot Numbers:
6C02A (Exp. 02/19)
5K42A (Exp. 09/2018)
7D47A (Exp. 03/2020)
Date Ranges: Expiration 02/2019, Expiration 09/2018, Expiration 03/2020

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 81193
Status: Resolved
Manufacturer: Akorn, Inc.
Manufactured In: United States
Units Affected: 149,159 5mL bottles
Distributed To: Nationwide
Agency Last Updated: January 28, 2019

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.